Guardant Health's Shield test gains EviCore coverage in 2027
Go back to Guardant Health's Shield test gains EviCore coverage in 2027| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 162.94 -3.72 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $166.66 | 52 Week High | $5.84 | |||
| Open | $165.03 | 52 Week Low | $5.49 | |||
| Day High | $167.25 | P/E | N/A | |||
| Day Low | $158.68 | EPS | $0.00 | |||
| Volume | 1,923,296 | |||||



